From the annual report. BCT is in with discussions with multiple manufacturers to incorporate its technology into their products. No other technology provides integrated wireless temperature reading and tracking. They have configured chips for different formats and sizes to access IVF, bloodbags and bio banking tubes. 44.25% owned by super and investment companies. Directors - Ian Kirkwood 27097732 shares, Andrew McLellan 7649999 shares 513926 performance rights, Michael Ohanessian 9247735 shares - belief in their product.
Latest news - Bosch has just been awarded a contract by CSL Behring to create a state of the art automatic materials handling line to increase productivity of plasma handling. Previously done manually. Can we assume that some one knows BCT may be involved?
BCT have been talking up their product at every quarterly report and with not much happening. I believe that the time is not far away from BCT realising its full potential
Keep the faith
From the annual report. BCT is in with discussions with multiple...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BCT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.616M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| BCT (ASX) Chart |
Day chart unavailable